Innoviz Technologies is an Israel-based developer and supplier of high-performance, automotive-grade LiDAR sensor platforms and complementary perception software. As a Tier-1 supplier, the company provides the sensing technology used in advanced driver-assistance systems (ADAS) and autonomous driving applications, including Level 3 and Level 4 programs. Its mature InnovizTwo/Innoviz 2 platform supports ongoing programs with customers including Volkswagen, Daimler Truck, and Mobileye (MBLY). More recently, Innoviz has extended its sensing solutions into defense and homeland security under the Perciz brand, targeting counter-unmanned aerial systems (counter-UAS) and perimeter security. Investors follow the stock for its exposure to autonomous-vehicle adoption and, increasingly, to defense-related demand, where average selling prices are materially higher than in automotive. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, INVZ shares declined approximately 59%, falling from a closing price of about $0.23 to roughly $0.10 per share. The move was broad-based and accelerated sharply in mid-November following the third-quarter earnings report and the reverse stock split announcement.
The decline over the last quarter is even steeper. From roughly $0.33 per share in mid-August, the stock has fallen by approximately 71%, reflecting a sustained downtrend rather than a single isolated event. The multi-month slide has been driven by persistent trading below Nasdaq's $1.00 minimum bid price, a revenue shortfall, and growing concerns about the company's listing status and cash runway.
Several verified catalysts combined to push shares lower over the last month. On November 11, Innoviz reported third-quarter 2026 revenue of $12.1 million, below analyst estimates, and lowered its full-year guidance to $44 million–$46 million. Management attributed the shortfall largely to a customer shifting its start-of-production timeline, which moved a meaningful portion of NRE revenue into 2027. Gross margin was negative 10.3% for the quarter, and the company announced a roughly 20% workforce reduction as part of an operational realignment expected to save about $17.5 million annually.
Listing compliance was the other dominant factor. On November 18, Innoviz announced a 1-for-20 reverse stock split intended to lift the share price above Nasdaq's $1.00 minimum bid requirement. The split is expected to take effect December 4, with split-adjusted trading to resume December 7. Because reverse splits do not change fundamentals and often signal persistent listing pressure, the announcement was met with selling. Adding to the pressure, analysts tempered their views, with JPMorgan (JPM) downgrading the stock to Hold and Goldman Sachs (GS) cutting its price target to $0.20 from $0.40.
The quarterly decline reflects a longer-running narrative of sub-$1 trading and ongoing Nasdaq compliance risk. Innoviz was first notified in March 2026 that its closing bid price had fallen below $1.00 for 30 consecutive business days. After the initial compliance period expired, Nasdaq granted an additional 180-day period through March 22, 2027. Shareholders approved a reverse split authorization of 1-for-5 to 1-for-20 in September.
At the same time, the company has been repositioning around two end markets. Its automotive business continues to progress programs with Volkswagen, Daimler Truck, and Mobileye (MBLY), while a newer defense segment gained recognition in September from MAFAT, Israel's Directorate of Defense Research and Development. Defense sales reached roughly 10% of third-quarter revenue, and management expects that share to grow to 20%–30% in 2027. Despite these efforts, ongoing cash burn, a revenue miss, and dilution concerns have kept sentiment firmly negative throughout the quarter.
Looking ahead, the most immediate catalyst is the reverse stock split. Its effectiveness is scheduled for December 4, with adjusted trading resuming December 7, and the key question is whether the stock can hold above $1.00 to satisfy Nasdaq's minimum bid requirement by the March 22, 2027 compliance deadline. Failure to sustain compliance could trigger further delisting proceedings.
Beyond listing mechanics, investors are likely to monitor the timing of NRE revenue recognition, conversion of the defense pipeline into firm orders, and the ramp of automotive programs. Management has indicated it expects volume defense orders in the first half of 2027 and projects its cash runway extending into 2028 without additional fundraising. Gross margin improvement, cost-discipline execution, and any new program wins will be important indicators of whether the company can stabilize its financial trajectory. Macroeconomic conditions, autonomous-vehicle adoption timelines, and competitive dynamics across the LiDAR industry also remain relevant risk factors. From what I see, these factors will shape the path forward.
In my research process, I frequently review Tickeron’s Trending AI Robots to examine automated trading strategies across various tickers. This page highlights top-performing bots with different approaches, timeframes, and metrics, offering a data-driven angle on risk management for names like INVZ. It helps put volatile moves into broader context without replacing personal analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 42 cases where INVZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +13.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 188 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 65 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for INVZ turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INVZ entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (0.781). P/E Ratio (-0.553) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM